VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
The neural mechanisms underlying the cellular and behavioral responses to antidepressants are not yet known. Up-regulation of growth factors and adult neurogenesis suggest a role for one or more of these factors in the action of antidepressants. One candidate of interest is vascular endothelial growth factor (VEGF), which was initially characterized for its role in angiogenesis, but also exerts direct mitogenic effects on neural progenitors in vitro . Results of this study demonstrate that VEGF is induced by multiple classes of antidepressants at time points consistent with the induction of cell proliferation and therapeutic action of these treatments. We find that VEGF signaling through the Flk-1 receptor is required for antidepressant-induced cell proliferation. We also show that VEGF-Flk-1 signaling is required and sufficient for behavioral responses in two chronic and two subchronic antidepressant models. Taken together, these studies identify VEGF and VEGF-Flk-1 signaling as mediators of antidepressant actions and potential targets for therapeutic intervention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a similar manner, VEGF also seems to be required for the behavioral action of various antidepressant drugs in rodent models of depression (Greene et al. 2009; Sun et al. 2012; Warner-Schmidt and Duman 2007; Warner-Schmidt and Duman 2008).”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Warner-Schmidt and Duman 2007
Citations
Cites
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Self-citationKuhn, H., Dickinson-Anson, H., & Gage, F. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-06-02027.1996 · Cited by 3,139
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
Self-citationNibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109
Self-citationThe fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth Factor
de Vries, C., Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N., & Williams, L. T. (1992) · Science · doi:10.1126/science.1312256 · Cited by 2,016
Willner, P., Towell, A., Sampson, D., Sophokleous, S., & Muscat, R. (1987) · Psychopharmacology · doi:10.1007/bf00187257 · Cited by 1,993
Vascular niche for adult hippocampal neurogenesis
Palmer, T. D., Willhoite, A. R., & Gage, F. H. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20001002)425:4<479::aid-cne2>3.0.co;2-3 · Cited by 1,838
Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654
Self-citation
Research works printed but not linked: 6
- TA Fong, LK Shawver, L Sun, C Tang, H App, TJ Powell, YH Kim, R Schreck, X Wang, W Risau, et al. Cancer Res 59, 99–106 (1999).
- DB Mendel, AD Laird, BD Smolich, RA Blake, C Liang, AL Hannah, RM Shaheen, LM Ellis, S Weitman, LK Shawver, JM Cherrington Anticancer Drug Des 15, 29–41 (2000).
- LM Strawn, G McMahon, H App, R Schreck, WR Kuchler, MP Longhi, TH Hui, C Tang, A Levitzki, A Gazit, et al. Cancer Res 56, 3540–3545 (1996).
- P Tapley, F Lamballe, M Barbacid Oncogene 7, 371–381 (1992).
- AM Duijvestijn, H van Goor, F Klatter, GD Majoor, E van Bussel, PJ van Breda Vriesman Lab Invest 66, 459–466 (1992).
- M Banasr, GW Valentine, XY Li, S Gourley, J Taylor, RS Duman Biol Psychiatry, in press. (2006).
Cited by
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Mechanisms and Functional Implications of Adult Neurogenesis
Zhao, C., Deng, W., & Gage, F. H. (2008) · Cell · doi:10.1016/j.cell.2008.01.033 · Cited by 3,007
The molecular neurobiology of depression
Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889
“), as well as vascular endothelial growth factor (VEGF) and VGF, which themselves have antidepressant and pro-neurogenic properties in rodent”
Belmaker, R. H., & Agam, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra073096 · Cited by 2,166
Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms
Pittenger, C., & Duman, R. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301574 · Cited by 1,795
“We have recently reported that chronic antidepressant administration, including SSRI, SNRI, and ECS, increases the expression of VEGF mRNA and protein in the hippocampus (Newton et al, 2003; Warner-Schmidt and Duman, 2007).”
BackgroundSelf-citation
Metadata
- Authors
- Warner-Schmidt, J. L., & Duman, R. S.
- Affiliations
- Departments of Psychiatry and Pharmacology, Yale University School of Medicine, New Haven, CT 06508
- Johns Hopkins University (US)
- Corresponding author
- Duman, Ronald S.
- ORCID
- Duman, Ronald S.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2007-03-13
- Volume
- 104
- Issue
- 11
- Pages
- 4647-4652
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1838655
- OpenAlex
- W2048398100
- Cited by
- 438
- References
- 56
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 9 · 2023: 14 · 2022: 17 · 2021: 11 · 2020: 15 · 2019: 18 · 2018: 19 · 2017: 15 · 2016: 23 · 2015: 30 · 2014: 32 · 2013: 33 · 2012: 38
- FWCI
- 10.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (MH45481)
- National Institute of Mental Health (MH 25642, MH-45481, R37MH045481, P01MH025642, R01MH045481)
- Topics
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- vascular endothelial growth factor, antidepressants, adult neurogenesis, neural progenitor proliferation, VEGF signaling, growth factors
- MeSH terms
- Animals, Antidepressive Agents, Behavior, Animal, Brain, Electroshock, Male, Neovascularization, Pathologic, Neurons, Signal Transduction, Rats, Sprague-Dawley, Vascular Endothelial Growth Factor Receptor-2, Vascular Endothelial Growth Factor A, Cell Proliferation, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. https://app.cochat.ai/papers/10.1073/pnas.0610282104
- The paper
- Warner-Schmidt, J. L., & Duman, R. S. (2007). VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0610282104
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.